Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Observational × Rectal Neoplasms × Focus Groups × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Breast Neoplasms 9 Neoplasms 6 Prostatic Neoplasms 5 Lung Neoplasms 3 Colorectal Neoplasms 3 Uterine Cervical Neoplasms 2 Thyroid Neoplasms 2 Lymphoma 2 Communication 2 Thyroid Diseases 1 Squamous Cell Carcinoma of Head and Neck 1 Smoking Cessation 1 Sexual Dysfunction, Physiological 1 Rectal Neoplasms 1 Patient Preference 1 Papillomavirus Infections 1 Papillary Thyroid Microcarcinoma 1 Neoplasms, Plasma Cell 1 Multiple Myeloma 1 Motor Activity 1 Melanoma 1 Leukemia 1 Hematologic Neoplasms 1 Health Behavior 1 HIV Infections 1 Coitus 1 Cancer Prevention 1 Cancer Pain 1 Brain Neoplasms 1 Attitude to Health 1

Interventions

Surveys and Questionnaires 9 Proctectomy 8 Capecitabine 8 Surgical Procedures, Operative 7 Radiotherapy 5 Oxaliplatin 5 Neoadjuvant Therapy 5 Psychiatric Rehabilitation 4 Blood Specimen Collection 4 Amplified Fragment Length Polymorphism Analysis 4 Robotic Surgical Procedures 3 Mastectomy, Segmental 3 Magnetic Resonance Spectroscopy 3 Immunohistochemistry 3 Endoscopic Mucosal Resection 3 Biopsy 3 tislelizumab 2 Ultrasonography 2 Transanal Endoscopic Surgery 2 Radiotherapy, Intensity-Modulated 2 Polymerase Chain Reaction 2 Observation 2 Mental Status and Dementia Tests 2 Laparoscopy 2 Interviews as Topic 2 Immunologic Techniques 2 Gene Expression Profiling 2 Chemotherapy, Adjuvant 2 Bevacizumab 2 saxagliptin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02551471 2018-08-09

PELVICARE

University Hospital, Bordeaux

Gastrointestinal

Rectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡